Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients.

Minajeva A, Kase M, Saretok M, Adamson-Raieste A, Kase S, Niinepuu K, Vardja M, Asser T, Jaal J.

Neurosci J. 2017;2017:5629563. doi: 10.1155/2017/5629563. Epub 2017 Nov 8.

2.

The Impact of Non-Lethal Single-Dose Radiation on Tumor Invasion and Cytoskeletal Properties.

Hohmann T, Grabiec U, Vogel C, Ghadban C, Ensminger S, Bache M, Vordermark D, Dehghani F.

Int J Mol Sci. 2017 Sep 18;18(9). pii: E2001. doi: 10.3390/ijms18092001.

3.

MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.

Alfardus H, McIntyre A, Smith S.

Biomed Res Int. 2017;2017:9157370. doi: 10.1155/2017/9157370. Epub 2017 Jul 19. Review.

4.

The Challenges of Management of High-grade Gliomas in Nigeria.

Ndubuisi CA, Mezue WC, Nzegwu M, Okwunodulu O, Ejembi G, Ohaegbulam SC.

J Neurosci Rural Pract. 2017 Jul-Sep;8(3):407-411. doi: 10.4103/jnrp.jnrp_18_17.

5.

Citation classics in neuro-oncology: assessment of historical trends and scientific progress.

Hachem LD, Mansouri A, Juraschka K, Taslimi S, Pirouzmand F, Zadeh G.

Neuro Oncol. 2017 Sep 1;19(9):1158-1172. doi: 10.1093/neuonc/nox053.

PMID:
28531344
6.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro A.

Neuro Oncol. 2017 Oct 1;19(10):1380-1390. doi: 10.1093/neuonc/nox086.

PMID:
28472509
7.

NovoTTF: where to go from here?

Cloughesy TF, Lassman AB.

Neuro Oncol. 2017 May 1;19(5):605-608. doi: 10.1093/neuonc/nox014. No abstract available.

PMID:
28453750
8.

Advances in epigenetic glioblastoma therapy.

Lee DH, Ryu HW, Won HR, Kwon SH.

Oncotarget. 2017 Mar 14;8(11):18577-18589. doi: 10.18632/oncotarget.14612. Review.

9.
10.

Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.

Kim EH, Kim YH, Song HS, Jeong YK, Lee JY, Sung J, Yoo SH, Yoon M.

Oncotarget. 2016 Sep 20;7(38):62267-62279. doi: 10.18632/oncotarget.11407.

11.

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy.

Zhou X, Liao X, Zhang B, He H, Shui Y, Xu W, Jiang C, Shen L, Wei Q.

Mol Clin Oncol. 2016 Aug;5(2):289-294. Epub 2016 Jun 15.

12.

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma.

Hau E, Shen H, Clark C, Graham PH, Koh ES, L McDonald K.

J Med Radiat Sci. 2016 Jun;63(2):114-23. doi: 10.1002/jmrs.149. Epub 2016 Jan 21. Review.

13.

Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review.

Zhao F, Li M, Kong L, Zhang G, Yu J.

Onco Targets Ther. 2016 May 27;9:3197-204. doi: 10.2147/OTT.S104241. eCollection 2016. Review.

14.

The influence of biomechanical properties and cannabinoids on tumor invasion.

Hohmann T, Grabiec U, Ghadban C, Feese K, Dehghani F.

Cell Adh Migr. 2017 Jan 2;11(1):54-67. doi: 10.1080/19336918.2016.1183867. Epub 2016 May 5.

15.

CNS Anticancer Drug Discovery and Development Conference White Paper.

Levin VA, Tonge PJ, Gallo JM, Birtwistle MR, Dar AC, Iavarone A, Paddison PJ, Heffron TP, Elmquist WF, Lachowicz JE, Johnson TW, White FM, Sul J, Smith QR, Shen W, Sarkaria JN, Samala R, Wen PY, Berry DA, Petter RC.

Neuro Oncol. 2015 Nov;17 Suppl 6:vi1-26. doi: 10.1093/neuonc/nov169.

16.

Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz).

Winter L, Oezerdem C, Hoffmann W, van de Lindt T, Periquito J, Ji Y, Ghadjar P, Budach V, Wust P, Niendorf T.

Radiat Oncol. 2015 Sep 22;10:201. doi: 10.1186/s13014-015-0510-9.

17.

GSK-3β regulates tumor growth and angiogenesis in human glioma cells.

Zhao P, Li Q, Shi Z, Li C, Wang L, Liu X, Jiang C, Qian X, You Y, Liu N, Liu LZ, Ding L, Jiang BH.

Oncotarget. 2015 Oct 13;6(31):31901-15. doi: 10.18632/oncotarget.5043.

18.

STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma.

Lau J, Ilkhanizadeh S, Wang S, Miroshnikova YA, Salvatierra NA, Wong RA, Schmidt C, Weaver VM, Weiss WA, Persson AI.

Cancer Res. 2015 Oct 15;75(20):4302-11. doi: 10.1158/0008-5472.CAN-14-3331. Epub 2015 Aug 17.

19.

Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model.

Yang C, Lee DH, Mangraviti A, Su L, Zhang K, Zhang Y, Zhang B, Li W, Tyler B, Wong J, Wang KK, Velarde E, Zhou J, Ding K.

Med Phys. 2015 Aug;42(8):4762-72. doi: 10.1118/1.4926550.

20.

Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.

Chaichana KL, Pinheiro L, Brem H.

Ther Deliv. 2015 Mar;6(3):353-69. doi: 10.4155/tde.14.114. Review.

Supplemental Content

Support Center